New Insights in COVID-19 Vaccine, Vaccine Hesitency, and Yearly Booster

A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366). This special issue belongs to the section "Infectious Diseases".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5784

Special Issue Editors


E-Mail Website
Guest Editor
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87106, USA
Interests: COVID-19 vaccination; COVID-19 vaccine hesitancy; COVID-19 vaccination in pregnancy; mix and match
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87106, USA
Interests: COVID-19 infection; hospital medicine; COVID-19 complications
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The COVID-19 pandemic has affected human life worldwide at every level, leading to widespread social, economic, personal, and emotional loss. The COVID-19 vaccine was developed at an unprecedented rate and is one of the most outstanding achievements of modern medicine. Unfortunately, however, while safe and effective vaccination is available to fight the pandemic and prevent hospital admission, morbidity, and mortality, vaccine hesitancy is still widespread, with many people refusing to vaccinate based on personal, religious, or political grounds. Importantly, vaccine hesitancy is widespread as regards both primary vaccination and booster doses.

With this aim in mind, in this Special Issue, we are looking to publish papers on recent developments in the COVID-19 vaccine as more and more vaccines are approved and become widely available worldwide. We are also looking to publish papers related to COVID-19 vaccine hesitancy in general and special populations and attitudes of the population toward recurrent annual COVID-19 booster doses.

We look forward to receiving original articles, reviews, or technical notes. 

Dr. Rahul Shekhar
Dr. Abu Baker Sheikh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19 vaccine hesitancy
  • COVID-19 vaccine side effect
  • COVID-19 vaccine in the immunocompromised population
  • COVID-19 vaccine annual booster dose
  • COVID-19 vaccine in the pregnant population

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

12 pages, 1827 KiB  
Article
COVID-19 Vaccination Intention in Patients with Autoimmune Diseases in Indonesia: An Application of the Integrated Behavioural Model
by Alvina Widhani, Dicky C. Pelupessy, Tommy Hariman Siddiq, Sukamto Koesnoe, Suzy Maria, Evy Yunihastuti, Ghina Shabrina Awanis, Teguh Harjono Karjadi, Anshari Saifuddin Hasibuan, Nanang Sukmana, Mulki Hakam, Kartika Qonita Putri, Insy Nafisah Taufik, Delina Widiyanti, Iris Rengganis and Samsuridjal Djauzi
Trop. Med. Infect. Dis. 2023, 8(2), 109; https://doi.org/10.3390/tropicalmed8020109 - 09 Feb 2023
Viewed by 1677
Abstract
Vaccine hesitancy can be a challenge for those with autoimmune diseases. This study investigated the acceptance of COVID-19 vaccination by patients with autoimmune diseases in Indonesia using the integrated behavioral model (IBM). This cross-sectional study was conducted from December 2021 to February 2022. [...] Read more.
Vaccine hesitancy can be a challenge for those with autoimmune diseases. This study investigated the acceptance of COVID-19 vaccination by patients with autoimmune diseases in Indonesia using the integrated behavioral model (IBM). This cross-sectional study was conducted from December 2021 to February 2022. A total of 404 patients with autoimmune diseases completed the survey. The majority of respondents (57.9%) said they intended to get vaccinated against COVID-19. The IBM model with added demographic variables explained 54.1% of the variance of vaccination intention (R2 = 0.541). Self-efficacy, perceived norms, experiential attitude, and instrumental attitude are significantly correlated with vaccination intention in components of health behavior theories. Self-efficacy is the most critical factor influencing vaccination intention in patients with autoimmune diseases (F(2, 401) = 96.9, p < 0.001, R2 = 0.326). In the multivariate analysis, vaccine intention was found to be positively associated with patients’ occupation as health-care workers (β = 0.105). Meanwhile, having a personal history of contracting COVID-19 and having co-morbidities other than autoimmune diseases were negatively correlated to the willingness to be vaccinated against COVID-19. This study confirms the viability of the IBM model for predicting the COVID-19 vaccination intention of patients with autoimmune diseases. It is essential to provide patients with autoimmune diseases with information that is clear and supported by evidence-based medicine. Full article
Show Figures

Figure 1

Other

Jump to: Research

23 pages, 791 KiB  
Systematic Review
Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review
by Yam B. Limbu and Bruce A. Huhmann
Trop. Med. Infect. Dis. 2023, 8(3), 159; https://doi.org/10.3390/tropicalmed8030159 - 05 Mar 2023
Cited by 14 | Viewed by 3475
Abstract
As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle. This study systematically analyzed research that examined the [...] Read more.
As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle. This study systematically analyzed research that examined the predictors of COVID-19 booster vaccine hesitancy. A search of PubMed, Medline, CINAHL, Web of Science, and Scopus uncovered 42 eligible studies. Globally, the average COVID-19 booster vaccination hesitancy rate was 30.72%. Thirteen key factors influencing booster hesitancy emerged from the literature: demographics (gender, age, education, income, occupation, employment status, ethnicity, and marital status), geographical influences (country, region, and residency), adverse events, perceived benefit/efficacy, perceived susceptibility, perceived severity, prior history of COVID-19 infection, vaccination status, vaccination recommendations, health status, knowledge and information, skepticism/distrust/conspiracy theories, and vaccine type. Vaccine communication campaigns and interventions for COVID boosters should focus on factors influencing booster confidence, complacency, and convenience. Full article
Show Figures

Figure 1

Back to TopTop